Inventor · disambiguated record
Kiev S. Ly
Also filed as: LY KIEV · LY KIEV S · LY KIEV SUI
22 granted patents·8 pending applications·186 citations·filing 2000–2024
95Inventor score
Files withJANSSEN PHARMACEUTICA NV11DART NEUROSCIENCE CAYMAN LTD4BRANSTETTER BRYAN JAMES2CARRUTHERS NICHOLAS I2DART NEUROSCIENCE LLC2
Top patents by PatentIndex Score
30 records- 0194US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0294US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 0393US6903088B2Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jun 7, 2005·31 cites·10 claims
- 0492US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 0592US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 0689US6803362B2Heterocyclic compoundsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 12, 2004·38 cites·37 claims
- 0788US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 0888US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 0987US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 1085USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 1185US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1284US8680275B2Fused heterocyclic compounds as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Mar 25, 2014·9 cites·20 claims
- 1379US10239882B2Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Mar 26, 2019·2 cites·20 claims
- 1478US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 1578US8637520B2Substituted pyridyl amide compounds as modulators of the histamine H3 receptorKEITH JOHN M·Filed 2010·Granted Jan 28, 2014·4 cites·4 claims
- 1677US8940731B2Substituted pyridyl amide compounds as modulators of the histamine H3 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 27, 2015·2 cites·5 claims
- 1777US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1872US9062044B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Jun 23, 2015·2 cites·18 claims
- 1971US7265135B22-oxy, 2-amino, and 2-thio-imidazole compoundsORTHO MCNEIL PHARM INC·Filed 2004·Granted Sep 4, 2007·6 cites·14 claims
- 2070US7414047B2Piperazinyl and diazapanyl benzamides and benzthioamidesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Aug 19, 2008·4 cites·26 claims
- 2164US9321729B2Substituted pyridyl amide compounds as modulators of the histamine H3 receptorJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 26, 2016·0 cites·14 claims
- 2263US2017129901A1Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2361US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 2458US2015335651A1DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2552US2009131417A1Substituted pyridyl amide compounds as modulators of the histamine h3 receptorLETAVIC MICHAEL A·Filed 2008·Application pending·0 cites
- 2652US2005085487A1Heterocyclic compoundsFiled 2004·Application pending·0 cites
- 2751US8236792B2Substituted pyrrolidine amides as modulators of the histamine H3 receptorCARRUTHERS NICHOLAS I·Filed 2009·Granted Aug 7, 2012·0 cites·40 claims
- 2845US7504426B2Heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Mar 17, 2009·0 cites·19 claims
- 2944US2002198237A1Heterocyclic compoundsFiled 2002·Application pending·0 cites
- 3039US2006194837A1Tetrahydroisoquinoline compoundsCARRUTHERS NICHOLAS I·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →